Datar Cancer Genetics products

TriNetra^™ is an advanced non-invasive blood test which provides evidence of an underlying malignancy via a safe, simple and quick blood draw. TriNetra^™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. TriNetra^™ enriches these CTCs from the blood sample and confirms their identity via a process called ‘Immunocytochemistry’ (ICC). A positive CTC finding is indicative of the presence of an underlying cancer whereas when CTCs are undetectable, the patient may not have a cancer.

Trucheck is an advanced non-invasive blood test which provides evidence of an underlying malignancy via a safe, simple and quick blood draw. Trucheck^™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Trucheck^™ enriches these CTCs from the blood sample and confirms their identity via a process called ‘Immunocytochemistry’ (ICC). A positive CTC finding is indicative of the presence of an underlying cancer whereas when CTCs are undetectable, the patient may not have a cancer.

EasyCheck 360 detects Circulating Tumor Cells (CTCs), which our research has shown to be present in most types of cancers. Our studies have shown that CTCs are detectable even in very early Stage 0 (in situ cancers) as well as Stage I and Stage II malignancies. CTCs are detected across all solid organ tumor types and subtypes, in men and women. CTCs do not exist in individuals without cancer. CTCs are undetectable in the blood of patients with non-cancerous (benign) tumors. CTCs, therefore, have high accuracy for the detection of cancer.

Exacta^™ is an intensive and in-depth multi-analyte tumor profiling. It analyses millions of data points at the molecular and functional levels to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection.

CellDx is an intensive and in-depth tumor molecular profiling. It analyses millions of data points at the molecular level to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection.